Moon Jong Youn, Jung Jaehun, Huh Kyungmin
Department of Preventive Medicine, Armed Forces Medical Command, Seongnam, Republic of Korea.
Division of Infectious Diseases, Department of Medicine, Armed Forces Capital Hospital, Seongnam, Republic of Korea.
Vaccine. 2017 Jul 13;35(32):3913-3916. doi: 10.1016/j.vaccine.2017.06.025. Epub 2017 Jun 19.
In response to the resurgence of mumps, the Korean Armed Forces started the measles-mumps-rubella (MMR) vaccination to all new recruits regardless of prior vaccination history. We evaluated the effectiveness of the vaccination by comparing the incidence between the military and civilian populations before and after implementation of the new policy. The standardized incidence ratio of mumps in the military was 7.06 in the prevaccine period, which declined to 0.96 in the postvaccine period. Vaccine effectiveness was estimated at 86.4%. Incidence rate ratio was lower in the 1996-1998 birth cohort (BC) compared with 1989-1995 BC (0.10 vs. 0.55), suggesting higher effectiveness of vaccination in the 1996-1998 BC. Our data provide evidence for the use of the MMR vaccination in the prevention of mumps in high-risk adults.
为应对腮腺炎疫情的再度出现，韩国武装部队对所有新兵开展了麻疹-腮腺炎-风疹（MMR）疫苗接种，无论其既往疫苗接种史如何。我们通过比较新政策实施前后军队和 civilian populations 之间的发病率来评估疫苗接种的有效性。在疫苗接种前时期，军队中腮腺炎的标准化发病率为7.06，在疫苗接种后时期降至0.96。疫苗有效性估计为86.4%。1996 - 1998年出生队列（BC）的发病率比低于1989 - 1995年BC（0.10对0.55），表明1996 - 1998年BC中疫苗接种的有效性更高。我们的数据为在高危成年人中使用MMR疫苗预防腮腺炎提供了证据。
原文中“civilian populations”表述有误，可能应该是“civilian population”，但按照要求未做修改直接翻译。
